These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

819 related items for PubMed ID: 11818393

  • 1. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
    McLeod DS, Taomoto M, Cao J, Zhu Z, Witte L, Lutty GA.
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
    [Abstract] [Full Text] [Related]

  • 2. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy.
    Taomoto M, McLeod DS, Merges C, Lutty GA.
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):230-43. PubMed ID: 10634625
    [Abstract] [Full Text] [Related]

  • 3. 5' nucleotidase and adenosine during retinal vasculogenesis and oxygen-induced retinopathy.
    Lutty GA, Merges C, McLeod DS.
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):218-29. PubMed ID: 10634624
    [Abstract] [Full Text] [Related]

  • 4. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.
    Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E.
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):290-9. PubMed ID: 8603833
    [Abstract] [Full Text] [Related]

  • 5. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy.
    McLeod DS, D'Anna SA, Lutty GA.
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1918-32. PubMed ID: 9727415
    [Abstract] [Full Text] [Related]

  • 6. Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy.
    Ishihama H, Ohbayashi M, Kurosawa N, Kitsukawa T, Matsuura O, Miyake Y, Muramatsu T.
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1172-8. PubMed ID: 11328724
    [Abstract] [Full Text] [Related]

  • 7. Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.
    Ozaki NK, Beharry KD, Nishihara KC, Akmal Y, Ang JG, Sheikh R, Modanlou HD.
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1546-57. PubMed ID: 11980873
    [Abstract] [Full Text] [Related]

  • 8. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW, Rajaratnam VS, Bullard LE, Yang R, Penn JS.
    Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
    [Abstract] [Full Text] [Related]

  • 9. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [Abstract] [Full Text] [Related]

  • 10. [Expression of mRNA of vascular endothelial growth factor in a rat model of hyperoxia-induced retinopathy].
    Zhang ZH, Jiang L, Qiao LX.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):371-4. PubMed ID: 17706045
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization.
    Suzuma K, Takagi H, Otani A, Suzuma I, Honda Y.
    Microvasc Res; 1998 Nov; 56(3):183-91. PubMed ID: 9828156
    [Abstract] [Full Text] [Related]

  • 12. Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.
    Werdich XQ, McCollum GW, Rajaratnam VS, Penn JS.
    Exp Eye Res; 2004 Nov; 79(5):623-30. PubMed ID: 15500821
    [Abstract] [Full Text] [Related]

  • 13. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith AC, Friedlander J, Friedlander M.
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [Abstract] [Full Text] [Related]

  • 14. Aquaporin-1 independent microvessel proliferation in a neonatal mouse model of oxygen-induced retinopathy.
    Ruiz-Ederra J, Verkman AS.
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4802-10. PubMed ID: 17898307
    [Abstract] [Full Text] [Related]

  • 15. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J, Afzal A, Pan H, Gallego E, Li N, Li Calzi S, Caballero S, Spoerri PE, Shaw LC, Grant MB.
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
    [Abstract] [Full Text] [Related]

  • 16. Lentivirus-mediated sFlt-1 gene fragment transfer suppresses retinal neovascularization.
    Min Z, Qiang W, Benwen S, Bin L, Xinhua D.
    Curr Eye Res; 2009 May; 34(5):401-10. PubMed ID: 19401884
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of retinal neovascularization by soluble EphA2 receptor.
    Chen J, Hicks D, Brantley-Sieders D, Cheng N, McCollum GW, Qi-Werdich X, Penn J.
    Exp Eye Res; 2006 Apr; 82(4):664-73. PubMed ID: 16359662
    [Abstract] [Full Text] [Related]

  • 18. Strain-dependent differences in oxygen-induced retinopathy in the inbred rat.
    van Wijngaarden P, Coster DJ, Brereton HM, Gibbins IL, Williams KA.
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1445-52. PubMed ID: 15790914
    [Abstract] [Full Text] [Related]

  • 19. [Pathogenesis of retinal neovascularization in a rat model of oxygen fluctuations-induced retinopathy].
    Liu X, Wang W, Wang AR, Ning Q, Luo XP.
    Zhonghua Er Ke Za Zhi; 2007 Jan; 45(1):7-13. PubMed ID: 17349140
    [Abstract] [Full Text] [Related]

  • 20. Riluzole inhibits VEGF-induced endothelial cell proliferation in vitro and hyperoxia-induced abnormal vessel formation in vivo.
    Yoo MH, Hyun HJ, Koh JY, Yoon YH.
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4780-7. PubMed ID: 16303979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.